Cargando…
Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy
Chronic obstructive pulmonary disease (COPD) is considered one of the leading causes of mortality. Cardiovascular comorbidities are diagnosed often in COPD patients, not only because of the common risk factors these two diseases share, but also because of the systemic inflammation which characterize...
Autores principales: | Papaporfyriou, Anastasia, Bartziokas, Konstantinos, Gompelmann, Daniela, Idzko, Marco, Fouka, Evangelia, Zaneli, Stavrina, Bakakos, Petros, Loukides, Stelios, Papaioannou, Andriana I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301030/ https://www.ncbi.nlm.nih.gov/pubmed/37374082 http://dx.doi.org/10.3390/life13061299 |
Ejemplares similares
-
IL-26 in the Lung and Its Role in COPD Inflammation
por: Bartziokas, Konstantinos, et al.
Publicado: (2022) -
Patient-Reported Outcome Measurements in Patients with COPD-Obstructive Sleep Apnea Overlap Syndrome: Time for Action?
por: Papaioannou, Andriana I, et al.
Publicado: (2022) -
Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control
por: Tsilogianni, Zoi, et al.
Publicado: (2015) -
Identification of asthma phenotypes using blood cell count
por: Papaioannou, Andriana I, et al.
Publicado: (2022) -
Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations
por: Bartziokas, Konstantinos, et al.
Publicado: (2023)